Skip to main content
. 2018 May 15;9(37):24837–24856. doi: 10.18632/oncotarget.24984

Figure 3. Principal inflammation-involved biomolecules affected by curative mushrooms: G. lucidum (left), and G. frondosa (right).

Figure 3